empty
 
 
ro
Search
Support
Instant account opening
Trading Platform
Deposit/Withdraw
Search
Pentru Începători Pentru Traderi Pentru Parteneri Luați o pauză Despre InstaSpot
ro
#DVAX Reveniți la lista instrumentelor #ELAN

Convertor valutar

DexCom Inc.
77.85 USD
09 Jun 2026 21:59
Modificarea pretului (% chg)
$0.01
(0.01%)
Inchidere
Inchidere

Pretul de inchidere, ziua precedenta.
$76.53
Deschiderea
Deschiderea

Pretul de deschidere.
$72.18
Petul maxim
Petul maxim

Pretul maxim al ultimei zile de tranzactionare.
$78.07
Pretul minim
Pretul minim

Pretul minim al ultimei zile de tranzactionare.
$75.96
52-sapt. max.
52-sapt. max.

Pretul maxim din ultimele 52 spatamani.
$78.07
52-sapt. min.
52-sapt. min.

Pretul minim din ultimele 52 saptamani.
$71.8
Descărcați arhiva
Cumpărați
77.85
Vindeți
77.85
Deschideți graficul în ecran complet
Cumpărați
77.85
Vindeți
77.85
Descărcați arhiva
Deschideți graficul în ecran complet

About DexCom Inc.

DexCom Inc. is a US-based medtech company established in 1999. The company is focused on developing and producing medical equipment. 

Its major product is a continuous glucose monitoring (CGM) system for people suffering from diabetes. The CGM system enables real-time continuous blood monitoring which is then transferred to a user's smart device.;

DexCom Inc. sells its products directly or through distributors in the United States and internationally. 

The company's market capitalization is currently estimated at $39.79 billion. Over the past year, it posted revenue of $2.448 billion and a net profit of $154.7 million. 

DexCom Inc. shares and what affects their value;

The shares of DexCom Inc. have been trading on the NASDAQ stock exchange under the ticker “DXCM” since 2005. The initial price of one share was $12.

At the moment, the stock is trading in the range between $99 and $103. Over the past year, the stock price fluctuated between a low of $66 and a high of $165.

What to consider when trading the asset:

  • The company has a good reputation and a brand that is recognized across the world;
  • Strong international presence;
  • The company develops its own mobile apps and prioritizes innovative technologies;
  • DexCom Inc. had no competitors for quite a long time. Today, however, other medical companies have presented a similar device and may easily claim its share in the market;
  • Strong competition forces the company to cut production costs and fight for customers’ attention by constantly improving its products;
  • The ability to collect data from patients using the company’s devices enables DexCom Inc. to develop personalized treatment plans.

Nu puteti sa vorbiti acum?
Puneti intrebare in chat.